Page last updated: 2024-09-03

mk 0663 and Liver Dysfunction

mk 0663 has been researched along with Liver Dysfunction in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cannon, CP; Connors, LG; Curtis, SP; Goldkind, L; Laine, L; Yanqiong, Z1
Agrawal, NG; Alam, I; Cote, J; Dilzer, SC; Geer, LA; Gottesdiener, KM; Larson, PJ; Lasseter, KC; Matthews, CZ; Petty, KJ; Porras, AG; Rose, MJ; Woolf, EJ1

Trials

2 trial(s) available for mk 0663 and Liver Dysfunction

ArticleYear
How common is diclofenac-associated liver injury? Analysis of 17,289 arthritis patients in a long-term prospective clinical trial.
    The American journal of gastroenterology, 2009, Volume: 104, Issue:2

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Chemical and Drug Induced Liver Injury; Cohort Studies; Cyclooxygenase Inhibitors; Diclofenac; Double-Blind Method; Etoricoxib; Female; Hospitalization; Humans; Liver Diseases; Male; Middle Aged; Osteoarthritis; Pyridines; Risk Factors; Sulfones

2009
Pharmacokinetics of etoricoxib in patients with hepatic impairment.
    Journal of clinical pharmacology, 2003, Volume: 43, Issue:10

    Topics: Administration, Oral; Aged; Area Under Curve; Biological Availability; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoricoxib; Female; Humans; Liver Diseases; Male; Middle Aged; Pyridines; Sulfones

2003